Bifidobacterium triple viable powder/capsule: How effective it is against gastrointestinal diseases?

Author:

Yu Jun1

Affiliation:

1. Institute of Digestive Disease and Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences The Chinese University of Hong Kong Hong Kong SAR China

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Reference22 articles.

1. Chinese expert consensus on the application of live combined Bifidobacterium, Lactobacillus, and Enterococcus powder/capsule in digestive system diseases (2021)

2. Clinical study on the eradication of Helicobacter pylori by compound Lactobacillus acidophilus tablets and Bifidobacterium triple viable capsules in combination with quadruple therapy;Zhang HT;Chin. J. Integr. Tradit. West Med. Dig.,2015

3. A probiotic treatment containing Lactobacillus, Bifidobacterium and Enterococcus improves IBS symptoms in an open label trial

4. Live combined Bifidobacterium, Lactobacillus and Enterococcus capsules/powder for the treatment of irritable bowel syndrome: a meta‐analysis;Li H;Chin. J. Pract. Intern. Med.,2016

5. Live combined Bifidobacterium, Lactobacillus and Enterococcus capsules/powder in the treatment of ulcerative colitis: a meta analysis;Li H;Chin. J. Pract. Intern. Med.,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3